Senolytic

What Is Senolytic

There is a family of tiny compounds known as senolytics that are now the subject of fundamental study to establish whether or not they may selectively trigger cell death in senescent cells and enhance human health. This study aims to find or create treatments that may postpone the onset of age-related disorders, prevent them, relieve their symptoms, or even reverse their effects. The term "senostatic," which meaning to inhibit senescence, is one that is associated with this idea.

How You Will Benefit

(I) Insights, and validations about the following topics:

Chapter 1: Senolytic

Chapter 2: Life extension

Chapter 3: Dasatinib

Chapter 4: p16

Chapter 5: CGK733 fraud

Chapter 6: Bcl-xL

Chapter 7: Chromatin remodeling

Chapter 8: Telomerase reverse transcriptase

Chapter 9: ID1

Chapter 10: Cellular senescence

Chapter 11: Fisetin

Chapter 12: NKG2D

Chapter 13: Human umbilical vein endothelial cell

Chapter 14: Genetics of aging

Chapter 15: Navitoclax

Chapter 16: Senotherapy

Chapter 17: ABT-737

Chapter 18: Senescence-associated secretory phenotype

Chapter 19: Hallmarks of aging

Chapter 20: Timeline of senescence research

Chapter 21: Laura Niedernhofer

(II) Answering the public top questions about senolytic.

(III) Real world examples for the usage of senolytic in many fields.

(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of senolytic' technologies.

Who This Book Is For

Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of senolytic.